Phase 1 Completed N=56 Randomized Triple-blind Basic Science

Mood Effects of Serotonin Agonists Extended

Healthy

Source: ClinicalTrials.gov NCT03934710 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2023

Primary outcomePrimary: DASS-21 — 2.9; 2.7; 4.5 units on a scale

Summary

In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.

Outcome Measures

Outcome	Result	p-value
PRIMARY DASS-21	2.9; 2.7; 4.5	—

Eligibility Criteria

Inclusion Criteria

English fluency
High school level education
BMI between 19 and 30

Exclusion Criteria

Diagnosed medical condition
women who are nursing, pregnant, or plan to become pregnant within 3 months
History of psychotic disorder or family history of psychotic disorder

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03934710). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.